Sign in
4

Changes in Ownership

Oruka Therapeutics, Inc. Filed Acc 0001104659-26-080009

Director sold 3,553,410 shares at $84.43 ($300,014,406)

  • Director acquired 3,553,410 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Fairmount Funds Management LLC · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-07-01 Conversion : show line 1 in the form +3,553,410 4,685,364 I
2026-07-01 Sale : show line 2 in the form −3,553,410 $84.43 $300,014,406 1,131,954 I
Open-market sales · 3,553,410 sh · avg $84.43 · $300,014,406

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-07-01 Conversion : show line 3 in the form Series B Preferred Stock −42,641 94,497 I
Loading xslF345X06/tm2619616-1_4seq1.xml…